Empirical Finance’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.13M | Buy |
12,974
+94
| +0.7% | +$8.21K | 0.06% | 270 |
|
|
2025
Q1 | $880K | Buy |
12,880
+346
| +3% | +$23.6K | 0.05% | 300 |
|
|
2024
Q4 | $975K | Sell |
12,534
-85
| -0.7% | -$6.61K | 0.06% | 276 |
|
|
2024
Q3 | $846K | Buy |
12,619
+364
| +3% | +$24.4K | 0.05% | 308 |
|
|
2024
Q2 | $1.39M | Sell |
12,255
-966
| -7% | -$110K | 0.09% | 190 |
|
|
2024
Q1 | $1.83M | Buy |
13,221
+462
| +4% | +$64.1K | 0.11% | 169 |
|
|
2023
Q4 | $1.58M | Buy |
12,759
+117
| +0.9% | +$14.5K | 0.11% | 172 |
|
|
2023
Q3 | $1.18M | Buy |
12,642
+1,333
| +12% | +$124K | 0.09% | 209 |
|
|
2023
Q2 | $1.45M | Buy |
11,309
+1,253
| +12% | +$161K | 0.11% | 162 |
|
|
2023
Q1 | $1.17M | Buy |
10,056
+597
| +6% | +$69.4K | 0.11% | 174 |
|
|
2022
Q4 | $1.07M | Buy |
9,459
+851
| +10% | +$96.4K | 0.11% | 178 |
|
|
2022
Q3 | $693K | Buy |
8,608
+1,587
| +23% | +$128K | 0.08% | 234 |
|
|
2022
Q2 | $523K | Buy |
7,021
+433
| +7% | +$32.3K | 0.07% | 269 |
|
|
2022
Q1 | $843K | Buy |
6,588
+1,512
| +30% | +$193K | 0.09% | 199 |
|
|
2021
Q4 | $681K | Buy |
5,076
+1,168
| +30% | +$157K | 0.08% | 226 |
|
|
2021
Q3 | $534K | Buy |
3,908
+308
| +9% | +$42.1K | 0.08% | 251 |
|
|
2021
Q2 | $384K | Buy |
3,600
+640
| +22% | +$68.3K | 0.06% | 289 |
|
|
2021
Q1 | $274K | Hold |
2,960
| – | – | 0.05% | 283 |
|
|
2020
Q4 | $274K | Buy |
2,960
+700
| +31% | +$64.8K | 0.05% | 283 |
|
|
2020
Q3 | $233K | Buy |
+2,260
| New | +$233K | 0.05% | 255 |
|